TSX:HLS (Hls Therapeutics)
About HLS
HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. The company was founded by Gregory Gubitz and Gilbert Godin on March 12, 2018 and is headquartered in Etobicoke, Canada.
Hls Therapeutics (TSX: HLS) Latest News
Dividend Stocks
2 Top Pharmaceutical Stocks to Buy on the TSX Today
Dividend Stocks
3 Biotech Stocks to Buy Before the Down Market Is Over
Investing
Got $4,000? 4 Cheap Stocks to Buy Right Now
Investing
2 Unstoppable Growth Stocks You Could Buy With Less Than $40
Coronavirus
Is HLS Therapeutics a Can’t-Miss Buy?
Investing
Got $1,000? 3 TSX Stocks to Buy Now
Investing
4 Undervalued Stocks to Buy With Just $500
Cannabis Stocks
Forget Aurora Cannabis: Here Are 2 Pot Stocks You Can Buy Instead!
Energy Stocks
3 Top Canadian Stocks to Buy in July
Investing
17 Top TSX Stock Picks for July 2021
Cannabis Stocks
Want to Play U.S. Cannabis Legalization? Consider This Top Canada-Listed Stock Today
Dividend Stocks
RRSP Investors: 3 Top TSX Stocks to Own in 2021
1❯